Antônio Vaz de Macedo

Immunophenotyping Investigation of Minimal Residual Disease Is a Useful Approach for Predicting Relapse in Acute Myeloid Leukemia Patients

Jesús F. San Miguel, Antônio Vaz de Macedo, María‐Belén Vídriales et al. · Blood · 1997 · 274 citations · Full text

Medicine, Hematology, Oncology +16

Characterization of aberrant phenotypes in acute myeloblastic leukemia

Antônio Vaz de Macedo, Alberto Órfão, María‐Belén Vídriales et al. · Annals of Hematology · 1995 · 89 citations

Medicine, Hematology, Oncology +14

Imatinib treatment duration is related to decreased estimated glomerular filtration rate in chronic myeloid leukemia patients

Milena Soriano Marcolino, Eric Boersma, Nelma Clementino et al. · Annals of Oncology · 2011 · 82 citations · Full text

Pharmacy, Hematology, Nephrology +10

Phenotypic analysis of CD34 subpopulations in normal human bone marrow and its application for the detection of minimal residual disease.

Antônio Vaz de Macedo, Alberto Órfão, Juana Ciudad et al. · PubMed · 1995 · 75 citations

Medicine, Cell Biology, Hematology +17

Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis: implications for minimal residual disease studies.

Antônio Vaz de Macedo, Alberto Orfao, Marcos González et al. · PubMed · 1995 · 75 citations

Medicine, Hematology, Immunology +17